Treatment of UTI in Pregnancy at 32 Weeks and 4 Days
For a pregnant patient at 32 weeks and 4 days gestation with a urinary tract infection, nitrofurantoin 50-100mg four times daily for 5-7 days is the recommended first-line treatment, as it is considered safe and effective during pregnancy with minimal transfer into breast milk. 1
First-Line Treatment Options
Nitrofurantoin 50-100mg QID for 5-7 days
Fosfomycin 3g single dose
Amoxicillin-clavulanate 500mg TID for 3-7 days
Important Considerations
Diagnostic Confirmation
- Obtain urinalysis and urine culture before initiating treatment 1
- Document positive urine cultures for future reference 1
Treatment Duration
- 5-7 days is recommended for uncomplicated cystitis 1, 3
- For pyelonephritis, 7-14 days of treatment is needed 1
- Hospitalization and IV antibiotics are indicated for pyelonephritis in pregnancy 3
Follow-Up
- Obtain a repeat urine culture 1-2 weeks after treatment to confirm eradication 1
- Monitor for symptoms of recurrence or progression to pyelonephritis
Medications to Avoid
- Fluoroquinolones - generally avoided in pregnancy 1, 2
- Tetracyclines - contraindicated in pregnancy 2
- Trimethoprim-sulfamethoxazole - avoid in third trimester due to risk of kernicterus 2
Clinical Pearls
- UTIs in pregnancy are associated with significant morbidity, including preterm birth, low birth weight, and spontaneous abortion if left untreated 2
- Physiologic changes in pregnancy (increased GFR, increased total body volume, enhanced cardiac output) may alter antibiotic pharmacokinetics 2
- Asymptomatic bacteriuria should also be treated in pregnancy to prevent progression to pyelonephritis 1
- E. coli remains the most common pathogen in UTIs 3
Common Pitfalls to Avoid
- Failing to obtain a urine culture before initiating treatment
- Using antibiotics with poor tissue penetration for suspected pyelonephritis
- Not confirming cure with a follow-up urine culture
- Prescribing fluoroquinolones or tetracyclines, which should be avoided in pregnancy
- Inadequate treatment duration, which may lead to recurrence or progression to pyelonephritis
By following these evidence-based recommendations, UTIs in pregnancy can be effectively managed while minimizing risks to both mother and fetus.